Chuck Triano | Senior Vice President, Investor Relations |
Albert Bourla | Chief Executive Officer |
Frank D'Amelio | Chief Financial Officer |
Angela Hwang | Group President, Biopharmaceuticals Group |
Mikael Dolsten | President, Worldwide Research and Development |
Doug Lankler | General Counsel |
Steve Scala | Cowen |
Tim Anderson | Wolfe Research. |
Terence Flynn | Goldman Sachs. |
Umer Raffat | Evercore ISI |
Chris Schott | JPMorgan |
Andrew Baum | Citi |
Jason Gerberry | Jason Gerberry |
Louise Chen | Cantor |
David Risinger | Morgan Stanley |
David Maris | Wells Fargo |
Mani Foroohar | SBC Leerink |
Navin Jacob | UBS |
Good day everyone and welcome to Pfizer's Second Quarter 2019 Earnings Conference Call. Today's call is being recorded.
At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead sir.